Archive for Февраль 20th, 2007
Targeting Peripheral CB1 Receptors May Avoid Acomplia (Rimonabant, Zimulti)
A diet drug Acomplia (Rimonabant, Zimulti) that selectively targets peripheral CB1 receptors such as those in the liver, instead of targeting all the body’s CB1 receptors including those in the brain like Acomplia (Rimonabant, Zimulti) , may help patients lose weight and lower [...]
